These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30076436)

  • 1. Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors.
    Abu Arja MH; Stanek JR; Finlay JL; AbdelBaki MS
    Childs Nerv Syst; 2018 Nov; 34(11):2179-2186. PubMed ID: 30076436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
    Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
    Robertson PL; Jakacki R; Hukin J; Siffert J; Allen JC
    J Neurooncol; 2014 May; 118(1):93-100. PubMed ID: 24700239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors.
    Murphy ES; Dhall G; Fangusaro J; Bartels U; Fouladi M; Shaw D; Khatua S; Hughes CW; Panigraphy A; Ioakeim-Ioannidou M; Souweidane M; Morris D; Gajjar A; Wu S; Onar-Thomas A; Haas-Kogan DA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):143-151. PubMed ID: 34990779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
    Schneider DT; Wessalowski R; Calaminus G; Pape H; Bamberg M; Engert J; Waag K; Gadner H; Göbel U
    J Clin Oncol; 2001 Apr; 19(7):1951-60. PubMed ID: 11283127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
    Sattar A; Masood M; Nisar H; Fatima I; Shahid AB
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):292-296. PubMed ID: 29615170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors.
    Chang TK; Wong TT; Hwang B
    Med Pediatr Oncol; 1995 Jun; 24(6):368-72. PubMed ID: 7536294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
    Bosl GJ; Yagoda A; Golbey RB; Whitmore W; Herr H; Sogani P; Morse M; Vogelzang N; MacDonald G
    Am J Med; 1985 Mar; 78(3):423-8. PubMed ID: 2983547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy.
    Sebag-Montefiore DJ; Douek E; Kingston JE; Plowman PN
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):345-50. PubMed ID: 1281421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
    Faure-Conter C; Orbach D; Cropet C; Baranzelli MC; Martelli H; Thebaud E; Vérité C; Rome A; Fasola S; Corradini N; Rocourt N; Frappaz D; Kalfa N; Patte C
    Pediatr Blood Cancer; 2014 Feb; 61(2):253-9. PubMed ID: 23940114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Outcome in Patients with Primary Central Nervous System Germ Cell Tumour: Clinical Experience from a Regional Cancer Centre in North India.
    Biswas A; Julka PK; Bakhshi S; Singh M; Rath GK
    Pediatr Neurosurg; 2017; 52(4):240-249. PubMed ID: 28538229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
    Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
    Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
    Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
    Balmaceda C; Heller G; Rosenblum M; Diez B; Villablanca JG; Kellie S; Maher P; Vlamis V; Walker RW; Leibel S; Finlay JL
    J Clin Oncol; 1996 Nov; 14(11):2908-15. PubMed ID: 8918487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
    Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
    Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
    Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.